Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,553 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Curis Inc | CRIS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.15 | 0.92% | 16.50 | 08:31:20 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 16.35 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 5 | 1,553 | - | 3.80 - 19.60 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:20:22 | 3 | $ 16.68 | USD |
Curis Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 96.37M | 5.89M | - | 10.02M | -47.41M | -8.04 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Curis News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRIS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 16.74 | 16.99 | 15.97 | 16.33 | 13,016 | -0.24 | -1.43% |
| 1 Month | 15.42 | 16.99 | 13.9914 | 15.46 | 13,814 | 1.08 | 7.00% |
| 3 Months | 10.15 | 17.49 | 9.04 | 13.14 | 26,061 | 6.35 | 62.56% |
| 6 Months | 6.30 | 17.49 | 5.25 | 10.59 | 62,633 | 10.20 | 161.90% |
| 1 Year | 16.066 | 19.60 | 3.80 | 13.23 | 155,854 | 0.434 | 2.70% |
| 3 Years | 205.60 | 348.00 | 3.80 | 86.48 | 1,382,808 | -189.10 | -91.97% |
| 5 Years | 37.60 | 348.00 | 3.80 | 96.85 | 1,570,994 | -21.10 | -56.12% |
Curis Description
| Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge. |
